Skip to main content

Table 1 Clinico-pathological characteristics of patients and samples

From: Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

Characteristics

 

N

Patient’s age, years

Median (range)

60 (26–86)

Sex

Female

41 (33%)

Male

84 (67%)

Smoker status

Current smoker

46 (46%)

Former smoker

43 (43%)

Non-smoker

11 (11%)

Pathological type

Non-squamous

22 (38%)

Squamous

47 (35%)

Mutational status

Mutateda

22 (38%)

Wild-type

36 (62%)

  1. a2 EGFR, 17 KRAS, 1 NRAS, 1 ROS1, 1 STK11 mutations